Status:

COMPLETED

An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD

Lead Sponsor:

Anhui Medical University

Conditions:

Transcranial Direct Current Stimulation

Parkinson Disease

Eligibility:

All Genders

Phase:

NA

Brief Summary

To demonstrate that intervention targeting the primary motor area (M1) using transcranial Direct Current Stimulation can improve sleep symptoms in patients with Parkinson's disease.

Detailed Description

Rapid eye movement sleep behavior disorder (RBD) is one of the most common accompanying symptoms of Parkinson's disease (PD). PD-RBD patients have more severe clinical manifestations, require larger d...

Eligibility Criteria

Inclusion

  • The diagnosis of PD was determined by neurologists with rich clinical work experience, and was in line with the diagnostic criteria for Parkinson's disease in China (2016 edition).
  • The total score of RBD Screening Questionnaire (RBDSQ) is ≥6 points.
  • All patients took the drug stably and had no history of drug adjustment within 2 months before treatment. The test was conducted 2 hours after taking the drug.
  • Good compatibility, with a certain degree of compliance;
  • Normal mental condition, able to cooperate with behavioral tests and transcranial electrical stimulation treatment;

Exclusion

  • The patient has a metal object or skull brace device or any similar metal object on the scalp;
  • Head tremor or limb shaking is so severe that it is difficult to calmly receive treatment;
  • The presence of other serious mental illness (such as major depression, psychosis or obsessive-compulsive disorder, physical illness or a history of substance abuse);
  • Have a head injury, stroke or other neurological disorder;
  • The diagnosis of PD dementia is difficult to complete the assessment.

Key Trial Info

Start Date :

January 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 30 2024

Estimated Enrollment :

17 Patients enrolled

Trial Details

Trial ID

NCT06566313

Start Date

January 1 2021

End Date

April 30 2024

Last Update

December 18 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cognitive Neuropsychology Lab Anhui Medical University

Hefei, Anhui, China